Ludovic Hacopian
Ludovic
Shaji Kalathil
Shaji Kalathil is currently the Executive Director, Head of IT for Global Medical Affairs and Hematology & Cell Therapy Medical Affairs at Bristol-Myers Squibb (BMS), having global responsibilities for all digital capabilities and services across Medical Affairs. Shaji is well recognized as a leader in driving digital transformation programs and has extensive experience in developing and executing technology vision and strategies at the domestic and global levels with specific focus on Medical Affairs, Commercial, Pharmacovigilance and Regulatory Affairs functions. Prior to joining BMS, Shaji worked at Novartis Pharmaceuticals for 13 years in various IT leadership roles. His last role with Novartis was as the Executive Director, Head of IT Strategy, Innovation & Enabling Technologies where he was responsible for leading digital innovation programs in Medical Affairs and Commercial. Shaji is a computer engineer by profession and prior to Novartis, he worked in the financial services sector leading teams to develop securities trading and clearance systems.
Victoria Elegant
Professor Victoria Elegant is based in Hong Kong for Amgen and is Vice-President, JAPAC Regional Medical Head, and Site Head, China Research Site, Shangha. Prior to Amgen, Professor Elegant was the Vice-President, Regulatory and Medical Affairs, APAC, based in Shanghai for 10 years for Baxter, and Vice President, Medical Affairs, Asia for Baxalta.
Professor Elegant is a Fellow of the Faculty of Pharmaceutical Medicine UK (FPM), member of the FPM International Committee, and is an Adjunct Professor, Faculty of Medicine and member of the Board of Studies for the Masters in Pharmaceutical Medicine at the University of New South Wales, Sydney, Australia.
She has published and spoken extensively on regulatory affairs, medical affairs and clinical development in the Asia Pacific region and is President of the Asia Pacific chapter of the Medical Affairs Professional Society (MAPS). She is on the biotech advisory board to the Hong Kong Stock Exchange.
Professor Elegant holds a medical degree from the University of London, and is passionate about improving standards of care and outcomes for patients in Asia. She is also involved in initiatives to support women in leadership.